Lakeland Industries, Inc. — Q1 FY2023 Form 10-Q Summary
Business Context and Reporting Period
Lakeland manufactures and sells industrial and public-sector protective clothing and accessories through more than 1,600 distributors and direct channels in over 50 countries. The filing covers the three months ended April 30, 2022, compared with the three months ended April 30, 2021. The financial statements are unaudited.
Key Financial Metrics
| Metric | Q1 FY2023 | Q1 FY2022 | Change |
|---|---|---|---|
| Net sales | $27.3 million | $34.1 million | Down 19.9% |
| Gross profit | $11.1 million | $14.8 million | Down 25.0% |
| Gross margin | 40.5% | 43.4% | Down 2.9 percentage points |
| Operating profit | $1.4 million | $6.6 million | Down 78.1% |
| Operating margin | 5.3% | 19.4% | Down 14.1 percentage points |
| Net income | $1.1 million | $5.0 million | Down 77.4% |
| Diluted EPS | $0.14 | $0.61 | Down $0.47 |
| Cash flow from operations | $1.9 million | $8.3 million | Down $6.4 million |
At April 30, 2022, cash and cash equivalents were $50.9 million, working capital was approximately $106.0 million, total assets were $142.6 million, and stockholders’ equity was $124.8 million. Inventory increased to $49.6 million from $47.7 million at January 31, 2022, primarily to offset freight delays and support planned inventory levels.
The Company had no borrowings outstanding under its $25.0 million secured revolving credit facility or its UK credit facility. It was in compliance with all debt covenants. The facility matures June 25, 2025.
Material Changes Versus the Prior Comparable Period
- Sales declined primarily because COVID-19-related direct container demand decreased, industrial-market demand remained soft, customers held excess channel inventory, and ocean-freight delays affected shipments.
- Disposable and chemical product sales declined, while fire, high-performance, and high-visibility product sales increased by approximately $1.6 million.
- Gross margin declined due mainly to lower direct-container sales and increased transportation costs.
- Operating expenses increased 18.5% to $9.6 million. Currency fluctuations, primarily involving the Chinese yuan, contributed approximately $0.8 million of the increase; travel, trade show, and administrative expenses also increased.
- Foreign-currency translation produced a $0.8 million other comprehensive loss, compared with a $0.1 million loss in the prior-year quarter.
- Cash decreased $1.9 million during the quarter as operating cash flow was offset by a $1.9 million additional investment in Bodytrak, $0.5 million of capital expenditures, $0.4 million of stock repurchases, and $0.7 million of shares withheld for employee taxes.
Outlook, Commentary, Risks, and Unusual Items
- Management expects approximately $3.0 million of fiscal 2023 capital expenditures for ERP deployment, strategic capacity expansion, equipment replacement, and related investments. The Company may also spend funds on acquisitions.
- Management believes existing cash and operating cash flow will fund projected working capital and planned capital expenditures for the foreseeable future.
- Management cited inflation, higher labor and freight costs, U.S. raw-material and precursor shortages, hiring and retention difficulties, wage inflation, and potential pressure on gross margins.
- Management warned that recessionary conditions and customer inventories accumulated during the pandemic could temper demand. The filing states that no material manufacturing capacity disruption from COVID-19 or raw-material shortages had occurred as of the filing date.
- Russia represented approximately 2.8% of Q1 FY2023 consolidated sales; Ukraine sales were not significant, and the Company had no capital assets in Russia. Management continued monitoring the effects of the Russia-Ukraine conflict.
- On April 28, 2022, the Company invested an additional $1.9 million in Bodytrak, increasing its ownership to 18.42%. The investment is accounted for under the equity method, and the Company recognized a $27,000 share of Bodytrak’s net loss.
- The reported effective tax rate was 20.2%, including a $0.2 million deferred tax benefit related to China social-tax accruals. Excluding that discrete benefit, the effective tax rate was 32.9%.
- The Company repurchased 25,017 shares for $0.4 million during the quarter. Approximately $5.4 million remained available under the existing and new repurchase programs at April 30, 2022.
- Key risks include international operations, foreign exchange, China exposure and tariffs, COVID-19 and geopolitical events, ERP implementation, demand forecasting and inventory levels, cybersecurity, product liability, environmental matters, competition, tax risks, and the success of acquisitions and investments.
Important Facts for Investors to Verify
- Whether demand in disposable and chemical product lines recovers as pandemic-related purchases and excess channel inventory normalize.
- Whether pricing actions offset freight, labor, raw-material, and inflationary cost increases and restore gross margins.
- Inventory aging, excess and obsolete reserves, and the potential effect of continued lower demand or freight disruptions.
- Bodytrak’s operating performance, valuation, funding needs, and potential contribution to Lakeland’s results.
- Cash availability by jurisdiction, including the potential 10% withholding tax on repatriation of China cash.
- Execution and cost impact of the global ERP rollout and the approximately $3.0 million fiscal 2023 capital-expenditure plan.
- Remaining authorization and timing for stock repurchases, as well as the effect of reduced share count on per-share results.
- Foreign-exchange effects, particularly from the Chinese yuan and other currencies, and developments related to Russia, Ukraine, and China operations.